Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jni P, Lettino M, Marx N, Mellbin LG, stgren CJ, Rocca B, Roffi M, Sattar N, Seferovi PM, Sousa-Uva M, Valensi P, Wheeler DC, ESC Scientific Document Group
10.1101/2024.10.11.617524(Accessed March 7, 2025)
Strategic Semaglutide in Georgetown, TX combines professional oversight with telehealth flexibility, ensuring patients receive structured weight loss support while avoiding unnecessary wait times and travel burdens
Semaglutide: Views from Endocrinology Experts Endocrinologists, specialists in diabetes management, have largely welcomed Semaglutide as a significant advancement in the treatment of type 2 diabetes